Vital launches new version of advanced visualization software

Vital Images Inc. has released Vitrea2, Version 3.7, the company's latest software for 2D, 3D and 4D visualization analysis.
   
Vitrea 2, Vital Images' flagship software, creates interactive 2D, 3D and 4D images from 2D information generated by CT, MR and PET scanners. The new release features Cardiac Functional Analysis (CFA), CT Lung options and an enhanced CT colonography application.
   
The CFA option visualizes a beating heart in 2D and 3D. Further, CFA measures the ejection fraction of the left ventricle. When used with Vital Images' CT Cardiac option, cardiologists can fully evaluate cardiac function in the CT environment, the company said.
   
The CT Lung application assists in lung cancer diagnosis, treatment and follow-up comparisons, Vital Images said. For example, a temporal comparison capability tracks changes in lung condition over time. The nodule probe tool automatically provides the dimension and volume of a nodule with a single click.
   
In addition, Version 3.7 includes enhancements to InnerviewGI, the company's CT colon software. The updated InnerviewGI option includes improvements to its hands-off fly-through capability that make it easier to examine the colon, along with the ability to move between 2D and 3D images with greater ease.
   
The American College of Radiology Imaging Network (ACRIN), a cooperative group that conducts cancer-related clinical trials, is using this version of InnerviewGI in a major clinical trial comparing CT colonography to traditional colonoscopy, Vital Images said.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.